Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of peptides inhibitory for thrombospondin dependent TGF-&bgr; activation in the treatment of kidney disease

Use of peptides inhibitory for thrombospondin dependent TGF-&bgr; activation in the treatment of kidney disease

US Patent 6458767 · Granted Oct 1, 2002

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for generation of pluripotent and multipotent cells2023
RF test hat2023
RF test hat2023
Piperazine-2,5-diones as TGF-beta inhibitors2022
RF test hat2022
RF test hat2022
Methods for modulating chemotherapeutic cytotoxicity2022
Prevention of tissue ischemia and related methods2022
Methods to eliminate cancer stem cells by targeting CD472021
Dipeptide analogs as TGF-beta inhibitors2021
Oxadiazoles and thiadiazoles as TGF-β inhibitors2021
Oxadiazoles and thiadiazoles as TGF-β inhibitors2020